BITS Pilani team to work for anti-HIV drugs

The research team in BITS Pilani Hyderabad campus which is working in the area of drug discovery, has received support from the Support Program for Scientific and Technological Cooperation between trilateral India, Brazil and South Africa (IBSA), funded by Department of Science and Technology (DST), India for their work in the area of a revolutionary anti-HIV drug.

BITS-Pilani, Hyderabad campus is one among the four top-of-the-line universities globally to receive this support.

Using their expertise and knowledge in the area, professors Dr Sriram and Dr P Yogeeswari have contributed to the drug design.

This project is aimed at coordinating the expertise in drug design, synthesis, natural product-based design, biochemists and medical professionals to come up with a novel anti-HIV drug.